SUSMED,Inc.(JP:4263)
Â¥258.00-12.00 (-4.44%)
JP:4263
SUSMED,Inc. financials statements
Â¥258.00
At close:-12.00 (-4.44%)
Want to see JP:4263 full AI Analyst Report?
SUSMED,Inc. (4263) Ratios
0 Followers
SUSMED,Inc. Ratios
JP:4263's free cash flow for Q4 2025 was ¥0.00. For the 2025 fiscal year, JP:4263's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
| Ratios | Jun 25 | Jun 24 | Jun 23 | Jun 22 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 27.40 | 35.43 | 15.24 | 56.29 | 22.63 |
| Quick Ratio | 27.40 | 35.43 | 15.24 | 56.29 | 22.63 |
| Cash Ratio | 25.16 | 34.92 | 15.08 | 55.93 | 22.47 |
| Solvency Ratio | -2.52 | -2.19 | -1.07 | -2.48 | -0.20 |
| Operating Cash Flow Ratio | -3.23 | -3.43 | -0.72 | -1.88 | 0.45 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | ¥ 3.88B | ¥ 4.33B | ¥ 4.57B | ¥ 4.84B | ¥ 4.86B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.04 | 1.03 | 1.07 | 1.02 | 1.05 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | -1482.32 | -9.39 | -111.06 |
| Interest Coverage Ratio | 0.00 | 0.00 | -1501.98 | -9.43 | -118.71 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.01 | 1.66 | 0.02 |
| Net Debt to EBITDA | 11.56 | 15.21 | 13.50 | 21.51 | 114.77 |
| Profitability Margins | |||||
| Gross Profit Margin | 96.50% | 97.35% | 96.58% | 96.73% | 98.49% |
| EBIT Margin | -66.40% | -64.19% | -106.54% | -72.32% | -9.34% |
| EBITDA Margin | -64.36% | -62.47% | -104.79% | -71.95% | -8.29% |
| Operating Profit Margin | -66.40% | -64.68% | -106.54% | -72.32% | -9.10% |
| Pretax Profit Margin | -76.20% | -64.19% | -103.98% | -73.58% | -9.34% |
| Net Profit Margin | -76.97% | -64.45% | -104.33% | -73.68% | -9.56% |
| Continuous Operations Profit Margin | -76.97% | -64.45% | -104.33% | -73.68% | -9.56% |
| Net Income Per EBT | 101.00% | 100.41% | 100.34% | 100.14% | 102.44% |
| EBT Per EBIT | 114.76% | 99.24% | 97.60% | 101.75% | 102.53% |
| Return on Assets (ROA) | -9.07% | -6.63% | -7.25% | -4.72% | -0.99% |
| Return on Equity (ROE) | -9.40% | -6.83% | -7.76% | -4.81% | -1.04% |
| Return on Capital Employed (ROCE) | -8.11% | -6.84% | -7.92% | -4.72% | -0.99% |
| Return on Invested Capital (ROIC) | -8.11% | -6.84% | -7.92% | -4.72% | -0.99% |
| Return on Tangible Assets | -9.27% | -6.65% | -7.26% | -4.72% | -1.00% |
| Earnings Yield | -2.62% | -2.91% | -3.93% | -2.92% | -0.57% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.82 | 30.06 | 33.02 | 33.10 | 48.61 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 280.44 | 30.36 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 77.66 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.12 | 0.10 | 0.07 | 0.06 | 0.10 |
| Working Capital Turnover Ratio | 0.12 | 0.10 | 0.07 | 0.10 | 0.11 |
| Cash Conversion Cycle | 202.27 | 24.17 | 11.05 | 11.03 | 7.51 |
| Days of Sales Outstanding | 200.97 | 12.14 | 11.05 | 11.03 | 7.51 |
| Days of Inventory Outstanding | 1.30 | 12.02 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 202.27 | 24.17 | 11.05 | 11.03 | 7.51 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -28.16 | -25.75 | -13.82 | -11.26 | 6.13 |
| Free Cash Flow Per Share | -32.55 | -26.01 | -14.38 | -12.12 | 5.02 |
| Dividend Paid and CapEx Coverage Ratio | -6.41 | -100.20 | -24.87 | -13.11 | 5.53 |
| Capital Expenditure Coverage Ratio | -6.41 | -100.20 | -24.87 | -13.11 | 5.53 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | -0.95 | -0.93 | -0.67 | -0.52 | 0.19 |
| Free Cash Flow Yield | -3.75% | -4.26% | -2.64% | -2.22% | 0.92% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -38.18 | -34.38 | -25.45 | -34.27 | -176.15 |
| Price-to-Sales (P/S) Ratio | 29.38 | 22.16 | 26.56 | 25.25 | 16.85 |
| Price-to-Book (P/B) Ratio | 3.59 | 2.35 | 1.98 | 1.65 | 1.84 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -26.63 | -23.49 | -37.90 | -44.98 | 108.48 |
| Price-to-Operating Cash Flow Ratio | -30.79 | -23.72 | -39.42 | -48.42 | 88.87 |
| Price-to-Earnings Growth (PEG) Ratio | -1.37 | 2.02 | -0.04 | 1.28 | 2.19 |
| Enterprise Value Multiple | -34.09 | -20.27 | -11.84 | -13.59 | -88.44 |
| Enterprise Value | 10.91B | 5.86B | 4.25B | 3.10B | 3.89B |
| EV to EBITDA | -34.09 | -20.27 | -11.84 | -13.59 | -88.44 |
| EV to Sales | 21.94 | 12.66 | 12.41 | 9.78 | 7.33 |
| EV to Free Cash Flow | -19.89 | -13.42 | -17.71 | -17.42 | 47.21 |
| EV to Operating Cash Flow | -22.99 | -13.56 | -18.42 | -18.75 | 38.68 |
| Tangible Book Value Per Share | 236.35 | 259.30 | 275.31 | 330.34 | 296.50 |
| Shareholders’ Equity Per Share | 241.58 | 260.27 | 275.82 | 330.34 | 296.96 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | -0.00 | -0.00 | -0.00 | -0.02 |
| Revenue Per Share | 29.51 | 27.57 | 20.52 | 21.58 | 32.35 |
| Net Income Per Share | -22.71 | -17.77 | -21.41 | -15.90 | -3.09 |
| Tax Burden | 1.01 | 1.00 | 1.00 | 1.00 | 1.02 |
| Interest Burden | 1.15 | 1.00 | 0.98 | 1.02 | 1.00 |
| Research & Development to Revenue | 0.50 | 0.59 | 0.71 | 0.71 | 0.33 |
| SG&A to Revenue | 1.13 | 1.03 | 1.32 | 0.98 | 0.74 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Income Quality | 1.24 | 1.45 | 0.65 | 0.71 | -2.03 |
Currency in JPY
